A preterm newborn at 26 weeks gestation is experiencing apnea of prematurity. The nurse is preparing to administer caffeine citrate as ordered. Which nursing intervention is most important before administering this medication?
1Check the infant's blood glucose level
2Assess the infant's feeding tolerance
3Monitor the infant's heart rate and rhythm✓ 정답
4Evaluate the infant's neurological status
해설
Monitoring heart rate and rhythm is most important before caffeine citrate due to its cardiovascular effects like tachycardia and arrhythmias. Other assessments are less critical pre-administration.
Understanding the Question
This question tests your ability to prioritize nursing interventions before administering a high-alert medication in the NICU. Caffeine citrate is a methylxanthine used as the first-line pharmacological treatment for apnea of prematurity (AOP). While it has significant neurological and respiratory benefits, it is also associated with specific adverse effects that require focused pre-administration assessment.
Why the Other Options Are Not the Priority
Before diving into the correct answer, it is helpful to understand why the other assessments, while important in the overall care of a preterm infant, are not the most critical safety check immediately before giving caffeine.
- Option 1: Check the infant's blood glucose level. Hypoglycemia is a common and serious problem in preterm infants. However, caffeine citrate administration is not directly linked to causing acute, severe hypoglycemia that would contraindicate giving the medication. Blood glucose monitoring is a standard part of ongoing NICU care, not a specific pre-caffeine safety check.
- Option 2: Assess the infant's feeding tolerance. Feeding intolerance is a frequent challenge in preterm neonates. While caffeine can increase metabolic rate and gastric acid secretion, assessing feeding tolerance is not the primary safety intervention required immediately before administering a dose. This assessment is more relevant for ongoing nutritional management.
- Option 4: Evaluate the infant's neurological status. AOP is fundamentally caused by nervous system immaturity, and caffeine works by stimulating the central nervous system [2]. While a baseline neurological assessment is part of overall care, the immediate pre-administration concern is not a detailed neuro exam but rather monitoring for the medication's cardiovascular effects, which can manifest acutely.
The Most Important Nursing Intervention: Cardiovascular Assessment
The correct answer is Option 3: Monitor the infant's heart rate and rhythm. This is the most critical nursing action based on the well-documented pharmacodynamics and adverse effect profile of methylxanthines.
- Mechanism of Action and Cardiac Effects: Caffeine is a methylxanthine that acts as a non-specific adenosine receptor antagonist. By blocking adenosine, it stimulates the central nervous system and increases the sensitivity of the respiratory center to carbon dioxide. However, this mechanism also causes direct cardiac stimulation and can lead to catecholamine release. The clinical consequence is a positive chronotropic effect, meaning it can significantly increase the heart rate and predispose the infant to tachyarrhythmias.
- Safety and Toxicity Monitoring: The therapeutic range for caffeine is narrow, and its metabolism is highly variable in preterm infants due to immature hepatic function, creating a risk of drug overaccumulation and toxicity . The most immediate and observable signs of caffeine toxicity are cardiovascular: marked tachycardia and cardiac arrhythmias. A prospective study on caffeine therapy highlights the importance of monitoring for complications related to overaccumulation, with cardiovascular effects being a primary concern . Therefore, establishing the infant's baseline heart rate and rhythm and ensuring they are stable before administering a dose is a fundamental patient safety measure. If the infant is already tachycardic or has an irregular rhythm, the nurse must hold the medication and notify the provider, as giving caffeine could dangerously exacerbate these conditions.
Clinical Context and Long-Term Benefits
While the immediate pre-administration focus is on cardiovascular safety, it is important to understand why this medication is used so extensively. Caffeine citrate, using a standard dosing regimen (loading dose 20 mg/kg, maintenance 5-10 mg/kg/day), is highly effective in treating AOP, a condition affecting at least 85% of infants born before 34 weeks' gestation . Beyond its immediate effect on apnea, its use is associated with significant long-term neurological benefits and improved outcomes for other organ systems . This knowledge underscores why a nurse must be meticulous in both safe administration and monitoring to ensure the infant receives the full therapeutic benefit without harm.
References (research sources)
[2]
Brain activity as a candidate biomarker for personalised caffeine treatment in premature neonates.Research articleUsman F, Zandvoort CS, Robinson S, Peck M, Cobo MM, Adjei T, Baxter L, Fry RE, Hauck AGV, Rogers R, Mellado GS, Scrivens A, van der Vaart M, De Vos M, Adams E, van den Anker J, Hartley C. (2026) · DOI: 10.3389/fped.2026.1792897
Clinical Practice Guide
Priority Pre-Administration Assessment for Caffeine Citrate
Primary Action: Assess apical heart rate and rhythm for a full 60 seconds. Caffeine citrate, a methylxanthine, acts as a cardiac stimulant and can cause tachycardia (HR > 180 bpm in preterm infants) and arrhythmias.
Safety Hold Parameter: Withhold the medication and notify the provider if the resting heart rate is persistently > 180 bpm or if a new irregular rhythm is detected.
Standard Nursing Protocol for Administration
Verify the correct dose in mg/kg based on the infant's current daily weight, as per the caffeine citrate loading or maintenance order.
Confirm the route (IV or PO) and ensure the oral syringe is calibrated for precise low-volume dosing.
Administer slowly over 15–30 minutes if given intravenously to minimize the risk of rapid cardiac stimulation.
Document the pre-administration heart rate, the dose given, and the infant's tolerance of the procedure.
Post-Administration Monitoring
Place the infant on a continuous cardiorespiratory monitor with pulse oximetry.
Observe for signs of caffeine toxicity: persistent tachycardia, jitteriness, feeding intolerance, or seizures.
Monitor for therapeutic effects: reduction in frequency and severity of apneic and bradycardic episodes.
Assess for common side effects such as transient diuresis and mild increases in gastric residuals.
Apnea of Prematurity (AOP) — A developmental disorder in preterm infants characterized by pauses in breathing for more than 20 seconds, or a shorter pause accompanied by bradycardia or oxygen desaturation, due to an immature respiratory center.
Caffeine Citrate — A methylxanthine medication and first-line pharmacological treatment for AOP that stimulates the central nervous system and increases diaphragmatic contractility, but carries a risk of tachycardia and arrhythmias.
Methylxanthine — A class of drugs that act as central nervous system stimulants and smooth muscle relaxants, known to increase heart rate and potentially cause cardiac arrhythmias.